NMPA Approval

Compound Aminophenazone and Barbital Injection

Approval Number

国药准字H20057895

Company葵花药业集团（冀州）有限公司

Registration Date

November 6, 2020

Drug Information

Generic Name

复方氨林巴比妥注射液

Dosage Form

注射剂

Strength

2ml:氨基比林0.1g,安替比林40mg,巴比妥18mg

Drug Type

化学药品

Registration Date

November 6, 2020

Company Information

Applicant Company

Company Name葵花药业集团（冀州）有限公司

Company Address

衡水市冀州区永兴西路588号

Manufacturing Company

Company Name葵花药业集团（冀州）有限公司

Company Address

衡水市开发区新区六路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方氨林巴比妥注射液 - NMPA 批准文号 | MedPath